Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05897242 · ClinicalTrials.gov registry record · NA

A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults

A NA study, sponsored by Fred Hutchinson Cancer Center.

Completed
Registry status
NA
Development phase
61
Enrollment target

NCT05897242 is a NA study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 61 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05897242, a NA study, has completed, sponsored by Fred Hutchinson Cancer Center.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target

Study Summary

Almost one in ten young adults report current e-cigarette use, putting them at risk of developing nicotine addiction and long-term health effects of exposure to inhaled toxicants. Despite the need for effective treatments to help these young users quit, very few treatments targeting any type of tobacco use among young adults have been evaluated, particularly for young adults who vape and have unique treatment needs. To address these needs, this trial will evaluate a digital program for young adult e-cigarette users at all stages of readiness to quit called ACT on Vaping.

Interventions

  • OTHER Survey Administration
  • OTHER Text Message
  • BEHAVIORAL Smartphone app

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2024-01-04
Est. Completion 2024-04-26
Phase NA

Sponsor

Fred Hutchinson Cancer Center

483 total trials

What the Registry Record Tells You About NCT05897242

The ClinicalTrials.gov registry entry for NCT05897242 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Survey Administration is the first listed.

NCT05897242 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05897242 about?

NCT05897242 is a clinical study titled "A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults". Almost one in ten young adults report current e-cigarette use, putting them at risk of developing nicotine addiction and long-term health effects of exposure to inhaled toxicants. Despite the need for effective treatments to help these young users quit, very few treatments targeting any type of toba...

What is the current status of trial NCT05897242?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2024-01-04. Estimated completion is 2024-04-26.

What interventions are being tested in trial NCT05897242?

The interventions under investigation include: Survey Administration (OTHER), Text Message (OTHER), Smartphone app (BEHAVIORAL).

Who is sponsoring clinical trial NCT05897242?

This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.